New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an ...

Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...

ORLANDO -- Adalimumab (Humira) was more effective than conventional immunosuppressive drugs at lowering or eliminating the ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q3 2025 Earnings Call October 22, 2025 4:30 PM EDT Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator ...

Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...

Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...

TOKYO/CAMBRIDGE - Eisai Co., Ltd. and Biogen Inc. (NASDAQ:BIIB), a prominent biotechnology company with a robust gross profit margin of 76.3% and strong financial health according to InvestingPro ...

Nassr’s Portuguese forward Cristiano Ronaldo (#7) celebrates after scoring during the Saudi Pro League match against Al-Riyadh SC at Al-Awwal Park in Riyadh on September 20, 2025, while Brazilian ...

When you hear the word, "debt," it's likely an immediate pit begins to form in your stomach. Debt means you owe money and if you don't pay it back, the balance you owe will grow even larger. But if ...

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...